Skip to main navigation

Investors

Press Releases

Press Releases

All
2026
2025
2024
2023
2022
2021
2020
2019
2018
2016

November 5, 2026

Adicet Bio Reports Third Quarter 2026 Financial Results and Provides Business Updates

October 30, 2026

Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

October 22, 2026

Adicet Bio to Participate in Upcoming Investor Conferences

September 30, 2026

Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

September 28, 2026

Adicet Bio Announces Positive Safety and Efficacy Data from Prula-cel (formerly ADI-001) Study in Patients with Systemic Lupus Erythematosus with or without Lupus Nephritis

September 25, 2026

Adicet Bio to Host Webcast to Present Prula-cel (formerly ADI-001) Clinical Data in Patients with Systemic Lupus Erythematosus with or without Lupus Nephritis

September 2, 2026

Adicet Bio to Participate in Fireside Chat at H.C. Wainwright 28th Annual Global Investment Conference

September 1, 2026

Adicet Bio Announces Completion of Last Patient Visit for Planned Analysis of prula-cel (formerly ADI-001) Study in Patients with Systemic Lupus Erythematosus With or Without Lupus Nephritis and Provides Corporate Update

August 31, 2026

Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

August 27, 2026

Adicet Bio Announces FDA Clearance of IND Application for ADI-212

Pagination

Current page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Displaying 1 - 10 of 210

Tools

Print

Print
Email Alerts

Email Alerts
Investor Contacts

Investor Contacts

IR Nav

Investors
Press Releases
Presentations & Events
Stock Information
Corporate Governance
Financial Information
Investor Resources

IR Nav

Investors
Press Releases
Presentations & Events
- Stock Quote & Chart
- Analyst Coverage
- Governance Highlights
- Leadership and Board of Directiors
Financial Information

Adicet - Header Navigation

About
Science
Pipeline
Investors
Careers
- Join Our Team
- Current Openings
Contact

IR Nav

Investors
Press Releases
Presentations & Events
Stock Information
- Stock Quote & Chart
- Analyst Coverage
Corporate Governance
- Governance Highlights
- Leadership and Board of Directiors
Financial Information
Investor Resources

© 2026 Adicet Bio All rights reserved. Website Design: Hane Chow, Inc.